Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...

(NewsNation) — Millions of Americans fighting obesity faced a setback last month when the Trump administration declined to allow Medicare and Medicaid to cover popular weight loss drugs like Wegovy ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Experts highlight the complex mix of genetics, biology and environment in obesity. Study shows fat cells' memory affects metabolism and weight management.

Access remains limited to these effective but expensive drugs, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.